44
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Comparison of the Gastrointestinal Side Effects of Naproxen Formulated as Plain Tablets, Enteric-Coated Tablets, Or Enteric-Coated Granules in Capsules

, , , , &
Pages 65-73 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Ran Li, Tian Yin, Yu Zhang, Jingxin Gou, Haibing He & Xing Tang. (2019) Preparing of aspirin sustained-release granules by hot-melt granulation and micro-crystal coating. Drug Development and Industrial Pharmacy 45:6, pages 959-967.
Read now
Tomasz Osmałek, Bartłomiej Milanowski, Anna Froelich, Sylwia Górska, Wojciech Białas, Mirosław Szybowicz & Marcin Kapela. (2017) Novel organogels for topical delivery of naproxen: design, physicochemical characteristics and in vitro drug permeation. Pharmaceutical Development and Technology 22:4, pages 521-536.
Read now
T. R. Meling, L. Aabakken, A. Røseth & M. Osnes. (1996) Faecal Calprotectin Shedding after Short-Term Treatment with Non-Steroidal Anti-Inflammatory Drugs. Scandinavian Journal of Gastroenterology 31:4, pages 339-344.
Read now
L. Aabakken, B. Olaussen, P. Mowinckel & M. Osnes. (1992) Gastroduodenal Lesions Associated with Two Different Piroxicam Formulations: An Endoscopic Comparison. Scandinavian Journal of Gastroenterology 27:12, pages 1049-1054.
Read now
O. Øktedalen, O. C. Lunde, P. K. Opstad, L. Aabakken & K. Kvernebo. (1992) Changes in the Gastrointestinal Mucosa after Long-Distance Running. Scandinavian Journal of Gastroenterology 27:4, pages 270-274.
Read now
Lars Aabakken. (1991) NSAIDs and the Gastrointestinal Tract—Case Closed?. Scandinavian Journal of Gastroenterology 26:8, pages 801-805.
Read now
L. Aabakken & M. Osnes. (1990) Gastroduodenal Lesions Induced by Naproxen: An Endoscopic Evaluation of Regional Differences and Natural Course. Scandinavian Journal of Gastroenterology 25:12, pages 1215-1222.
Read now
L. Aabakken & M. Osnes. (1990) 51Cr-Ethylenediaminetetraacetic Acid Absorption Test: Effects of Naproxen, a Non-Steroidal, Antiinflammatory Drug. Scandinavian Journal of Gastroenterology 25:9, pages 917-924.
Read now
L. Aabakken, S. Larsen & M. Osnes. (1989) Cimetidine Tablets or Suspension for the Prevention of Gastrointestinal Mucosal Lesions Caused by Non-steroidal, Anti-inflammatory Drugs. Scandinavian Journal of Rheumatology 18:6, pages 369-375.
Read now
L. Aabakken, S. Larsen & M. Osnes. (1989) Sucralfate for Prevention of Naproxen-induced Mucosal Lesions in the Proximal and Distal Gastrointestinal Tract. Scandinavian Journal of Rheumatology 18:6, pages 361-368.
Read now
L. Aabakken, J. H. Dybdahl, S. Larsen, P. Mowinckel, M. Osnes & H. Quiding. (1989) A Double-blind Comparison of Gastrointestinal Effects of Ibuprofen Standard and Ibuprofen Sustained Release Assessed by Means of Endoscopy and 51Cr-labelled Erythrocytes. Scandinavian Journal of Rheumatology 18:5, pages 307-313.
Read now
O. N. Gamst. (1989) Oral Naproxen Formulations. Scandinavian Journal of Gastroenterology 24:sup163, pages 44-47.
Read now

Articles from other publishers (15)

Tomasz Z Osmałek, Anna Froelich, Marcin Soból, Bartłomiej Milanowski, Marcin Skotnicki, Paweł Kunstman & Mirosław Szybowicz. (2018) Gellan gum macrobeads loaded with naproxen: The impact of various naturally derived polymers on pH-dependent behavior. Journal of Biomaterials Applications 33:1, pages 140-155.
Crossref
Ingvar Bjarnason, Ozgur Sancak, Anne Crossley, Andrew Penrose & Angel Lanas. (2018) Differing disintegration and dissolution rates, pharmacokinetic profiles and gastrointestinal tolerability of over the counter ibuprofen formulations. Journal of Pharmacy and Pharmacology 70:2, pages 223-233.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 27 32 .
K.D. Rainsford & Ingvar Bjarnason. 2015. Ibuprofen. Ibuprofen 363 429 .
R. D’Arienzo, R. Stefanile, F. Maurano, G. Mazzarella, E. Ricca, R. Troncone, S Auricchio & M. Rossi. (2011) Immunomodulatory Effects of Lactobacillus casei Administration in a Mouse Model of Gliadin-Sensitive Enteropathy. Scandinavian Journal of Immunology 74:4, pages 335-341.
Crossref
Ingvar Bjarnason & Ken Takeuchi. (2009) Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. Journal of Gastroenterology 44:S19, pages 23-29.
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 2426 2429 .
Dorsey M. Bass, Mary Prevo & Deborah S. Waxman. (2002) Gastrointestinal Safety of an Extended-Release, Nondeformable, Oral Dosage Form (OROS??)*. Drug Safety 25:14, pages 1021-1033.
Crossref
Davies. (2001) Review article: non‐steroidal anti‐inflammatory drug‐induced gastrointestinal permeability. Alimentary Pharmacology & Therapeutics 12:4, pages 303-320.
Crossref
Alan W. Baird, Cormac T. Taylor & David J. Brayden. (1997) Non-antibiotic anti-diarrhoeal drugs: factors affecting oral bioavailability of berberine and loperamide in intestinal tissue. Advanced Drug Delivery Reviews 23:1-3, pages 111-120.
Crossref
Maryanne V. Skeljo, Andrew S. Giraud & Neville D. Yeomans. (1993) Gastric mucosal damage induced by nonsalicylate nonsteroidal antiinflammatory drugs in rats is mediated systemically. Digestive Diseases and Sciences 38:11, pages 2038-2042.
Crossref
Ingvar Bjarnason, Paul Smethurst, Andrew Macpherson, Francis Walker, James C. McElnay, A.Peter Passmore & Ian S. Menzies. (1992) Glucose and citrate reduce the permeability changes caused by indomethacin in humans. Gastroenterology 102:5, pages 1546-1550.
Crossref
L. AABAKKEN. (2007) Review article: non‐steroidal, antiinflammatory drugs—the extending scope of gastrointestinal side effects. Alimentary Pharmacology & Therapeutics 6:2, pages 143-162.
Crossref
G. R. DAVIES & D. S. RAMPTON. (2007) The pro‐drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non‐steroidal anti‐inflammatory drugs. Alimentary Pharmacology & Therapeutics 5:6, pages 593-598.
Crossref
A. Del Favero. 1991. 92 109 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.